Patents by Inventor Asuragen, Inc.

Asuragen, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIAGNOSTIC MIRNAS FOR DIFFERENTIAL DIAGNOSIS OF INCIDENTAL PANCREATIC CYSTIC LESIONS
    Publication number: 20140100124
    Abstract: Embodiments concern methods and compositions for characterizing or evaluating neoplastic pancreatic cells using miRNAs that are measured and used in calculations to determine a risk score for a patient.
    Type: Application
    Filed: March 13, 2013
    Publication date: April 10, 2014
    Applicant: Asuragen, Inc.
    Inventor: Asuragen, Inc.
  • MICRORNAS DIFFERENTIALLY EXPRESSED IN CERVICAL CANCER AND USES THEREOF
    Publication number: 20130184175
    Abstract: The present invention concerns methods and compositions for identifying a miRNA profile for a particular condition, such as cervical disease, and using the profile in assessing the condition of a patient.
    Type: Application
    Filed: January 7, 2013
    Publication date: July 18, 2013
    Applicant: Asuragen, Inc.
    Inventor: Asuragen, Inc.
  • METHODS AND COMPOSITIONS INVOLVING MIRNA EXPRESSION LEVELS FOR DISTINGUISHING PANCREATIC CYSTS
    Publication number: 20130157884
    Abstract: Embodiments concern methods and compositions for evaluating a pancreatic cyst in a patient based on the expression levels of one or more miRNAs to determine whether the pancreatic cyst is a low or high risk lesion and in further need of treatment such as resection.
    Type: Application
    Filed: October 26, 2012
    Publication date: June 20, 2013
    Applicant: Asuragen, Inc.
    Inventor: Asuragen, Inc.
  • METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES
    Publication number: 20130143945
    Abstract: The present invention concerns methods and compositions for introducing miRNA activity or function into cells using synthetic nucleic acid molecules. Moreover, the present invention concerns methods and compositions for identifying miRNAs with specific cellular functions that are relevant to therapeutic, diagnostic, and prognostic applications wherein synthetic miRNAs and/or miRNA inhibitors are used in library screening assays.
    Type: Application
    Filed: February 7, 2013
    Publication date: June 6, 2013
    Applicant: ASURAGEN, INC.
    Inventor: Asuragen, Inc.
  • MIRNAS AS DIAGNOSTIC BIOMARKERS TO DISTINGUISH BENIGN FROM MALIGNANT THYROID TUMORS
    Publication number: 20130142728
    Abstract: Embodiments concern methods and compositions for distinguishing benign from malignant thyroid tumors in a patient based on the expression levels of one or more miRNAs.
    Type: Application
    Filed: October 27, 2012
    Publication date: June 6, 2013
    Applicant: Asuragen, Inc.
    Inventor: Asuragen, Inc.